PROPHYLAXIS: A STRATEGY TO MINIMISE ANTIVIRAL RESISTANCE
- 26 May 1984
- journal article
- Published by Elsevier in The Lancet
- Vol. 323 (8387) , 1154-1155
- https://doi.org/10.1016/s0140-6736(84)91396-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Acyclovir Prophylaxis Against Herpes Simplex Virus Infection in Patients with LeukemiaAnnals of Internal Medicine, 1983
- Mode of action of acyclovir triphosphate on herpesviral and cellular DNA polymerasesAntiviral Research, 1982
- Acyclovir chemistry and spectrum of activityThe American Journal of Medicine, 1982
- Acyclovir inhibition of viral DNA chain elongation in herpes simplex virus-infected cellsThe American Journal of Medicine, 1982
- Mechanism of action and selectivity of acyclovirThe American Journal of Medicine, 1982
- Herpes simplex virus variants restraint to high concentrations of acyclovir exist in clinical isolatesAntimicrobial Agents and Chemotherapy, 1982
- Acyclovir Prophylaxis of Herpes-Simplex-Virus InfectionsNew England Journal of Medicine, 1981
- Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci.Proceedings of the National Academy of Sciences, 1980
- Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1.Proceedings of the National Academy of Sciences, 1980
- Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanineProceedings of the National Academy of Sciences, 1977